Yahoo
NYSE - Delayed Quote USD

Pediatrix Medical Group, Inc. (MD)

29.82 +0.64 (+2.19%)
At close: October 30 at 4:00:02 PM EDT
29.82 0.00 (0.00%)
After hours: October 30 at 5:05:00 PM EDT
Trade MD on Coinbase
Chart Range Bar
Loading chart for MD
  • Previous Close 29.18
  • Open 29.48
  • Bid 28.20 x 60000
  • Ask 30.78 x 20000
  • Day's Range 29.07 - 29.97
  • 52 Week Range 17.23 - 30.55
  • Volume 1,114,250
  • Avg. Volume 763,335
  • Market Cap (intraday) 2.33B
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) 16.30
  • EPS (TTM) 1.83
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 28.50
  • Zacks Rating Neutral

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

www.pediatrix.com

4,280

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MD
39.41%
S&P 500 (^GSPC)
10.73%

1-Year Return

MD
71.48%
S&P 500 (^GSPC)
11.11%

3-Year Return

MD
161.35%
S&P 500 (^GSPC)
81.91%

5-Year Return

MD
9.51%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 501.37M
Earnings 46.99M
Profit Margin 9.37%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
300M
400M
500M
7.0%
8.0%
9.0%

Analyst Insights

View More

Analyst Price Targets

28.00 Low
28.50 Average
29.82 Current
30.00

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/30/2026
Analyst Truist Securities
Rating Action Maintains
Rating Hold
Price Action Raises
Price Target 28 -> 31

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.66%

  • Return on Assets (ttm)

    6.86%

  • Return on Equity (ttm)

    17.25%

  • Revenue (ttm)

    1.96B

  • Net Income Avi to Common (ttm)

    150.09M

  • Diluted EPS (ttm)

    1.83

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    425.84M

  • Total Debt/Equity (mrq)

    72.03%

  • Levered Free Cash Flow (ttm)

    141.31M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: